GIUGGIOLI, DILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.152
EU - Europa 17.854
AS - Asia 15.874
SA - Sud America 2.104
AF - Africa 389
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 20
Totale 68.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.491
IT - Italia 6.914
SG - Singapore 4.753
GB - Regno Unito 4.679
CN - Cina 4.185
HK - Hong Kong 1.809
BR - Brasile 1.611
VN - Vietnam 1.492
SE - Svezia 1.236
DE - Germania 976
BD - Bangladesh 969
FI - Finlandia 888
FR - Francia 772
UA - Ucraina 601
RU - Federazione Russa 579
KR - Corea 545
TR - Turchia 539
IN - India 403
CA - Canada 334
ID - Indonesia 294
NL - Olanda 246
BG - Bulgaria 233
MX - Messico 191
AR - Argentina 187
JP - Giappone 158
ZA - Sudafrica 133
IQ - Iraq 99
IE - Irlanda 96
ES - Italia 94
PL - Polonia 90
AE - Emirati Arabi Uniti 86
PK - Pakistan 82
AT - Austria 69
MY - Malesia 66
CO - Colombia 63
EC - Ecuador 63
BE - Belgio 56
EG - Egitto 51
LT - Lituania 51
MA - Marocco 47
CL - Cile 46
SA - Arabia Saudita 44
TN - Tunisia 42
VE - Venezuela 42
AU - Australia 40
RO - Romania 40
PH - Filippine 39
IR - Iran 38
CZ - Repubblica Ceca 33
PE - Perù 32
CH - Svizzera 31
NP - Nepal 30
PY - Paraguay 29
TH - Thailandia 28
UZ - Uzbekistan 28
BZ - Belize 27
KE - Kenya 26
JO - Giordania 24
TW - Taiwan 23
CR - Costa Rica 20
AZ - Azerbaigian 19
AL - Albania 18
ET - Etiopia 17
HU - Ungheria 16
OM - Oman 16
PT - Portogallo 16
DZ - Algeria 15
GR - Grecia 15
BY - Bielorussia 14
IL - Israele 14
BO - Bolivia 13
EU - Europa 13
UY - Uruguay 13
DO - Repubblica Dominicana 12
JM - Giamaica 12
LV - Lettonia 12
GT - Guatemala 11
SN - Senegal 11
DK - Danimarca 10
KZ - Kazakistan 10
PS - Palestinian Territory 10
HN - Honduras 9
KG - Kirghizistan 9
BB - Barbados 8
BH - Bahrain 8
GE - Georgia 8
NG - Nigeria 8
RS - Serbia 8
SY - Repubblica araba siriana 8
EE - Estonia 7
LU - Lussemburgo 7
MD - Moldavia 7
SI - Slovenia 7
BA - Bosnia-Erzegovina 6
HR - Croazia 6
NO - Norvegia 6
PA - Panama 6
QA - Qatar 6
SK - Slovacchia (Repubblica Slovacca) 6
SV - El Salvador 6
Totale 68.316
Salva come PNG Salva come JPEG
Città #
Southend 3.361
Santa Clara 3.161
Singapore 3.045
Ashburn 2.816
Fairfield 2.599
Hong Kong 1.783
Woodbridge 1.481
San Jose 1.441
Hefei 1.420
Chandler 1.325
Houston 1.217
Jacksonville 951
Seattle 946
Chicago 920
Wilmington 916
Council Bluffs 867
Cambridge 829
Los Angeles 825
Ann Arbor 740
London 686
Nyköping 679
Helsinki 668
Beijing 638
Dearborn 622
Milan 548
New York 510
Seoul 506
Ho Chi Minh City 477
Rome 432
Salt Lake City 428
The Dalles 423
Modena 395
Hanoi 375
Izmir 298
San Diego 289
Lauterbourg 253
Bologna 235
Princeton 234
Buffalo 228
Sofia 224
Jakarta 219
Dallas 206
Tampa 198
Elk Grove Village 168
Moscow 162
Eugene 157
São Paulo 156
Frankfurt am Main 152
Shanghai 151
Naples 150
Florence 127
Bremen 120
Atlanta 119
Orem 112
Palermo 111
Redwood City 104
Des Moines 102
Tokyo 97
Columbus 93
Munich 93
Phoenix 90
Toronto 90
Mexico City 87
Boardman 86
Guangzhou 86
Dublin 80
Sterling 80
Turin 78
Parma 77
Lancaster 76
Catania 75
Bari 74
Montreal 71
Da Nang 70
Miami 67
Warsaw 67
Chennai 66
Denver 66
Kent 65
Johannesburg 64
Detroit 63
Genoa 60
Falls Church 59
Haiphong 59
Verona 58
Redondo Beach 54
Amsterdam 52
Reggio Emilia 51
Stockholm 51
Norwalk 50
Dulles 49
Manchester 49
Brooklyn 47
Padova 47
New Delhi 44
Ovada 43
San Francisco 43
Belo Horizonte 42
Lappeenranta 42
Mumbai 42
Totale 45.108
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.855
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 957
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 783
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 761
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 482
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 455
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 449
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 440
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 433
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 423
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 391
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 388
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 388
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 384
Thymus alterations and systemic sclerosis 383
Heart involvement and systemic sclerosis 377
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 375
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 373
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 372
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 372
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 367
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 367
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 357
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 356
Current treatment of hepatitis C-associated rheumatic diseases. 355
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 354
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 353
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 347
Scleroderma digital ulcers complicated by infection with fecal pathogens. 345
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 345
Aortic pulse wave velocity measurement in systemic sclerosis patients. 342
Elevated Troponin Serum Levels in Adult Onset Still's Disease 341
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 341
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 338
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 331
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 329
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 328
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 325
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 324
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 324
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 324
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 322
Associations between Systemic Sclerosis and Thyroid Diseases 322
L-Arginine in pregnant scleroderma patients 322
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 320
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 318
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 316
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 316
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 315
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 314
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 311
Platelet gel in the treatment of severe scleroderma skin ulcers. 310
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 309
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 307
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 307
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 304
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 303
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 301
HCV and cryoglobulinemic vasculitis. 296
HHV-6A infection and systemic sclerosis: Clues of a possible association 296
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 294
Insights into the knowledge of complex diseases: Environmental infectious/ toxic agents as potential etiopathogenetic factors of systemic sclerosis 290
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 287
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 286
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 286
Cardiovascular risk and prostanoids in systemic sclerosis 285
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 285
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 282
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 282
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 281
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 280
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 279
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 278
Amlodipine in the treatment of Raynaud's phenomenon 277
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 277
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 275
HCV associated cryoglobulinemic vasculitis 275
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 275
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 273
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 273
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 271
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 268
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 268
Renal Manifestations of Hepatitis C Virus 263
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 261
Systemic sclerosis following human cytomegalovirus infection 261
Micro and Nanoparticles As Possible Causative-Prognostic Co-Factors Of Mixed Cryoglobulinemia Syndrome 258
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 258
The safety of iloprost in systemic sclerosis in a real-life experience 258
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 257
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 257
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 257
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 256
Treatment of HCV-related mixed cryoglobulinemia 255
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 255
HCV-related rheumatic manifestations and therapeutic strategies 254
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 254
Novel Therapies for Thyroid Autoimmune Diseases 254
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 253
[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease and Graves'ophthalmopathy] 252
Totale 36.733
Salva come PNG Salva come JPEG
Categoria #
all - tutte 263.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 263.213
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021303 0 0 0 0 0 0 0 0 0 0 0 303
2021/20224.403 221 363 353 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/202512.041 472 216 243 827 2.233 1.779 830 635 1.329 769 1.254 1.454
2025/202626.057 1.487 901 1.908 3.429 4.661 1.679 2.907 1.147 2.189 2.092 2.084 1.573
Totale 69.020